There is a lot of debate these days about the costs of medical care, and the risks.
On Monday, the American College of Physicians issued new ethical guidelines on whether doctors should consider costs when deciding how to treat patients.
Click here for NPR's podcast and transcript: http://tinyurl.com/7v2lcuh
Sources: NPR; Modern Healthcare
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Targeted Treatment May Improve Outcomes in IDH1-Mutated MDS
January 13th 2025A pair of abstracts presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exhibition suggest that IDH1-targeted treatment may improve survival among patients with myelodysplastic syndromes (MDS) with the mutation.
Read More